tiprankstipranks
Bioventus (BVS)
NASDAQ:BVS
US Market

Bioventus (BVS) Ratios

188 Followers

Bioventus Ratios

BVS's free cash flow for Q4 2025 was $0.66. For the 2025 fiscal year, BVS's free cash flow was decreased by $ and operating cash flow was $0.16. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Mar 23
Liquidity Ratios
Current Ratio
1.70 1.70 1.31 1.53 0.90
Quick Ratio
1.19 1.19 0.87 1.01 0.62
Cash Ratio
0.32 0.32 0.20 0.21 0.10
Solvency Ratio
0.15 0.15 0.03 -0.17 -0.11
Operating Cash Flow Ratio
0.47 0.46 0.18 0.09 -0.04
Short-Term Operating Cash Flow Coverage
3.89 3.85 1.42 0.55 -0.41
Net Current Asset Value
$ -182.27M$ -182.27M$ -266.74M$ -321.79M$ -687.85M
Leverage Ratios
Debt-to-Assets Ratio
0.46 0.46 0.46 0.49 0.30
Debt-to-Equity Ratio
1.69 1.69 2.27 2.27 1.29
Debt-to-Capital Ratio
0.63 0.63 0.69 0.69 0.56
Long-Term Debt-to-Capital Ratio
0.60 0.60 0.68 0.68 0.54
Financial Leverage Ratio
3.71 3.71 4.92 4.67 4.22
Debt Service Coverage Ratio
2.34 2.34 0.67 -0.34 -1.71
Interest Coverage Ratio
2.15 2.21 -0.31 -2.01 -13.91
Debt to Market Cap
0.45 0.60 0.49 1.20 2.61
Interest Debt Per Share
5.07 5.07 5.73 6.95 7.01
Net Debt to EBITDA
2.46 2.46 7.50 -15.51 -3.19
Profitability Margins
Gross Profit Margin
67.32%67.32%67.72%64.06%64.65%
EBIT Margin
10.31%10.31%-1.80%-15.70%-34.56%
EBITDA Margin
18.58%18.58%6.84%-4.50%-23.75%
Operating Profit Margin
10.04%10.31%-2.09%-15.95%-32.66%
Pretax Profit Margin
4.53%4.53%-8.57%-23.64%-36.91%
Net Profit Margin
4.00%4.00%-5.85%-30.49%-30.99%
Continuous Operations Profit Margin
4.80%4.80%-7.65%-23.66%-28.25%
Net Income Per EBT
88.42%88.42%68.28%129.00%83.96%
EBT Per EBIT
45.05%43.91%410.10%148.19%113.03%
Return on Assets (ROA)
3.33%3.33%-4.61%-19.27%-11.56%
Return on Equity (ROE)
13.79%12.35%-22.67%-90.00%-48.80%
Return on Capital Employed (ROCE)
10.91%11.19%-2.31%-12.86%-15.65%
Return on Invested Capital (ROIC)
10.52%10.79%-1.96%-12.32%-11.62%
Return on Tangible Assets
7.39%7.39%-10.62%-48.65%-21.88%
Earnings Yield
3.44%4.59%-4.89%-47.32%-99.05%
Efficiency Ratios
Receivables Turnover
4.43 4.43 4.50 4.17 3.76
Payables Turnover
16.99 16.99 7.81 7.99 4.93
Inventory Turnover
2.26 2.26 2.00 2.02 2.14
Fixed Asset Turnover
21.02 21.02 17.10 10.26 11.60
Asset Turnover
0.83 0.83 0.79 0.63 0.37
Working Capital Turnover Ratio
4.91 6.39 7.27 16.78 20.16
Cash Conversion Cycle
222.63 222.63 216.78 222.84 194.06
Days of Sales Outstanding
82.44 82.44 81.11 87.48 97.14
Days of Inventory Outstanding
161.68 161.68 182.40 181.03 170.90
Days of Payables Outstanding
21.48 21.48 46.73 45.66 73.99
Operating Cycle
244.11 244.11 263.51 268.50 268.04
Cash Flow Ratios
Operating Cash Flow Per Share
1.12 1.11 0.59 0.24 -0.22
Free Cash Flow Per Share
1.08 1.07 0.58 0.13 -0.24
CapEx Per Share
0.04 0.04 0.02 0.12 0.02
Free Cash Flow to Operating Cash Flow
0.97 0.97 0.97 0.52 1.11
Dividend Paid and CapEx Coverage Ratio
29.15 28.87 38.56 2.08 -9.16
Capital Expenditure Coverage Ratio
29.15 28.87 38.56 2.08 -9.16
Operating Cash Flow Coverage Ratio
0.24 0.24 0.12 0.04 -0.03
Operating Cash Flow to Sales Ratio
0.13 0.13 0.07 0.03 -0.03
Free Cash Flow Yield
10.80%14.41%5.51%2.42%-9.37%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
29.04 21.81 -20.46 -2.11 -1.01
Price-to-Sales (P/S) Ratio
1.18 0.87 1.20 0.64 0.31
Price-to-Book (P/B) Ratio
3.59 2.69 4.64 1.90 0.49
Price-to-Free Cash Flow (P/FCF) Ratio
9.26 6.94 18.16 41.36 -10.67
Price-to-Operating Cash Flow Ratio
8.84 6.70 17.69 21.52 -11.84
Price-to-Earnings Growth (PEG) Ratio
0.16 -0.13 0.26 0.55 >-0.01
Price-to-Fair Value
3.59 2.69 4.64 1.90 0.49
Enterprise Value Multiple
8.79 7.16 24.99 -29.82 -4.51
Enterprise Value
927.73M 755.78M 980.27M 688.03M 548.11M
EV to EBITDA
8.79 7.16 24.99 -29.82 -4.51
EV to Sales
1.63 1.33 1.71 1.34 1.07
EV to Free Cash Flow
12.87 10.58 25.94 86.20 -36.50
EV to Operating Cash Flow
12.42 10.22 25.27 44.84 -40.49
Tangible Book Value Per Share
-2.21 -2.21 -3.47 -4.29 -3.83
Shareholders’ Equity Per Share
2.76 2.76 2.26 2.77 5.30
Tax and Other Ratios
Effective Tax Rate
-0.06 -0.06 0.11 >-0.01 0.23
Revenue Per Share
8.53 8.53 8.77 8.18 8.34
Net Income Per Share
0.34 0.34 -0.51 -2.49 -2.59
Tax Burden
0.88 0.88 0.68 1.29 0.84
Interest Burden
0.44 0.44 4.75 1.51 1.07
Research & Development to Revenue
0.02 0.02 0.02 0.03 0.05
SG&A to Revenue
0.55 0.55 0.57 0.59 0.64
Stock-Based Compensation to Revenue
0.02 0.00 0.02 <0.01 0.03
Income Quality
3.13 0.00 -122.00 -0.13 0.09
Currency in USD